Vermont Controlled Substance Treatment Agreements, documented from the statewide rule outward

Status: Vermont evidence build reviewed through October 4, 2026. This library separates the statewide Department of Health mandate, professional monitoring duties, workers’ compensation consequences, implementation guidance, enforcement history, and future practice-specific agreements.

Use this Vermont record

What is required Vermont’s Rule Governing the Prescribing of Opioids for Pain requires a signed Controlled Substance Treatment Agreement before opioid treatment for chronic pain.
Who it applies to Covered patients with chronic pain lasting more than 90 consecutive days and the prescribers subject to the statewide rule.
Who can change it The Vermont Department of Health controls the statewide rule through formal rulemaking.
What to do next See the rulemaking route or submit a Vermont agreement.

Current legal baseline

Vermont’s Rule Governing the Prescribing of Opioids for Pain, effective April 1, 2024, requires a signed Controlled Substance Treatment Agreement before prescribing opioids for chronic pain. Chronic pain is defined as pain lasting longer than 90 consecutive days.

Requirement Current Vermont rule
Signed treatment agreement Required before opioid treatment for chronic pain.
Functional goals Required agreement subject.
Dispensing pharmacy Required agreement subject.
Safe storage and disposal Required agreement subjects.
Additional monitoring terms May include directly observed urine testing and pill counts as determined by the prescriber.
Stable-patient reevaluation No less frequently than every 90 days.
Agreement review No less frequently than once every 365 days.

State-level records

VPMS is a separate legal layer

Vermont law requires Prescription Monitoring System queries in defined circumstances, including at least annually for ongoing opioid treatment and when beginning long-term pain therapy. Those duties are separate from the agreement itself, even if a practice mentions them in its patient contract.

Higher-dose safeguards

At doses above 90 MME per day, Vermont requires enhanced reevaluation, review of the agreement and informed consent, an in-person overdose-risk discussion, and naloxone or documented possession of an opioid antagonist. Concurrent opioid-benzodiazepine use also triggers the antagonist requirement.

Workers’ compensation consequence

Vermont’s current workers’ compensation rules incorporate the Department of Health opioid rule. If credible evidence shows noncompliance in chronic-pain prescribing, a rebuttable presumption may arise that the opioid treatment is not reasonable medical treatment for the claim. The injured worker can still prove the treatment reasonable, and discontinuance requires a safe taper supported by medical evidence.

Enforcement history

Board of Medical Practice orders have treated missing treatment agreements, failure to review agreements annually, inadequate urine testing, absent VPMS queries, and related chronic-pain documentation problems as enforceable professional-compliance issues. Historical cases are preserved as implementation evidence, not substitutes for the 2024 rule.

Current implementation evidence

The University of Vermont AHEC opioid-prescribing toolkit provides a Vermont-specific workflow in which staff check whether agreements are current, providers review agreements with patients, and signed agreements are scanned into the medical record. Those workflow details are implementation guidance, not additional statewide legal mandates.

Practice-agreement evidence gap

The current public search located strong state, workers’ compensation, enforcement, and implementation evidence but fewer current publicly posted Vermont clinic-specific agreement texts. This library does not fill that gap with generic national forms or unverified copies. Current practice agreements will be added when their Vermont source and use can be verified.

Formal change route

The agreement mandate is in the Department of Health rule. Under 3 V.S.A. §806, any person may ask the agency to adopt, amend, or repeal a rule; within 30 days the agency must initiate rulemaking, act on the request, or deny it with written reasons. The current Commissioner of Health is Rick Hildebrant, MD.

Submit a missing Vermont agreement

Submit a Vermont Contract for Care

Primary Vermont authorities

Reviewed: October 4, 2026.

Evidence boundary: Vermont’s agreement mandate is statewide and binding for covered chronic-pain opioid treatment. Practice-added clauses, implementation workflows, workers’ compensation consequences, and historical enforcement records remain distinct evidence layers.